Low-Concentration Atropine for Myopia Progression (LAMP) Study
Considering myopia control options for your patients? Find out what the latest clinical literature says about the available management strategies.
Blog
2024
Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide
TAKE-HOME MESSAGE
Endophthalmitis After Anti-VEGF Intravitreal Injections With Aqueous Chlorhexidine vs Povidone–Iodine as Antiseptics
TAKE-HOME MESSAGE
FL-41 Tint Reduces Activation of Neural Pathways of Photophobia in Patients with Chronic Ocular Pain
An evaluation of responses to light stimuli measured using functional MRI in a cohort of patients with chronic ocular pain, dry eye symptoms, and photophobia...
2023
FDA warns consumers not to purchase or use certain eye drops from several major brands due to risk of eye infection
Find out the list of eye drops to avoid here.
New update on dry Macular Degeneration treatment: SYFOVRE® (pegcetacoplan injection) from Apellis Pharmaceuticals
On August 22, 2023, Apellis Pharmaceuticals provided an update on their SYFOVRE® (pegcetacoplan injection) treatment for Dry Macular Degeneration.